Back to discover
Disease

Mobility Limitation

Late-stage therapeutic developmentEmerging research
MeSHMobility Limitation
1
Publications
6
Clinical trials
2021
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q1 2032.
Upcoming Milestones
Major developments
Major clinical milestoneHigh impact
TESTO-TRIAL: Randomized Clinical Trial on the Use of Testosterone in Critically Ill Patients
Primary completion2026-08-02
Upcoming trial readoutImportant
IMProving Mobility After revasCularizaTion in Peripheral Artery Disease: The IMPACT PAD Trial
Results expected Q1 20322025-08-26
Clinical Milestones2View
Results expected 1
Recently completed 1
Activity timeline2

Clinical trials

6 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
6
All trials
2
Active
3
Late-stage
3
Completed
Late-stage studies

IMProving Mobility After revasCularizaTion in Peripheral Artery Disease: The IMPACT PAD Trial

Phase 3 · Recruiting · Northwestern University

TESTO-TRIAL: Randomized Clinical Trial on the Use of Testosterone in Critically Ill Patients

Phase 4 · Active, not recruiting · Leticia Maria Defendi Barboza Marson

Optimizing Protein Intake in Older Americans With Mobility Limitations

Phase 3 · Completed · Brigham and Women's Hospital

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes1
  • Survivors1
Leading journals1
  • JAMA network open1
Leading researchers8
  • Ba DM1
  • Chinchilli VM1
  • Ericson JE1
  • Groff D1
  • Lekoubou A1
  • Oh JS1
  • Parsons N1
  • Poudel GR1
Affiliations (unnormalised)4
  • Center for Neural Engineering1
  • Mary Mackillop Institute for Health Research1
  • Penn State College of Medicine and Milton S. Hershey Medical Center1
  • School of Psychology1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Difficulty in walking from place to place.

Identifiers
MeSHMobility Limitation
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.